By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Medivir AB 

Lunastigen 7

Huddinge    141 44  Sweden
Phone: 46-8-608-3100 Fax: 46-8-608-3199




GlaxoSmithKline (North Carolina) 

Peptimmune, Inc.  Development agreement for inhibitors of Cathepsin S for autoimmune and allergic diseases.

Company News
New Members of Medivir AB (MVRBF)’s Management Group 3/2/2015 10:50:57 AM
Medivir AB (MVRBF): Financial Statement, January – December 2014 2/27/2015 11:30:10 AM
Presentation Of The Result Of Medivir AB (MVRBF)’s Voluntary Redemption Programme 2/27/2015 10:22:34 AM
Medivir AB (MVRBF)’s Nomination Committee Proposes New Board Of Directors Ahead Of 2015 AGM 2/18/2015 10:48:09 AM
Final Terms For Medivir AB (MVRBF)’s Voluntary Redemption Programme 1/30/2015 11:01:52 AM
Medivir AB (MVRBF)’s CEO Increases His Shareholding In The Company 1/27/2015 12:47:31 PM
Medivir AB (MVRBF) Makes Change Within The Management Team 1/21/2015 11:07:48 AM
Medivir AB (MVRBF): OLYSIO® Sales During The Fourth Quarter 2014 1/20/2015 11:35:30 AM
Medivir AB (MVRBF): MIV-802 Has Been Selected As A Candidate Drug And Enters Non-Clinical Development For The Treatment Of Hepatitis C Infection 12/22/2014 11:51:00 AM
Medivir AB (MVRBF): Interim Report, January – September 2014 11/20/2014 11:35:40 AM